X0508 4 2026-01-16 0001133416 GALECTIN THERAPEUTICS INC GALT 0001266773 CALLICUTT JACK W C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240 NORCROSS GA 30071 false true false false Chief Financial Officer true Stock option (right to buy) 3.04 2026-01-16 4 A false 65000 0 A 2036-01-16 Common Stock 65000 65000 D Restricted Stock Unit 2026-01-16 4 A false 100000 0 A Common Stock 100000 100000 D Issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. The options vest as follows: 25% on each of June 30, 2026? December 31, 2026? June 30, 2027? and December 31, 2027. Restricted Stock Units vest 100% on the earlier of December 31, 2026 or signing of a partnership agreement. The Restricted Stock Units, if vested, convert into Common Stock on a one for one basis. Jack W. Callicutt 2026-01-21